Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Post-Traumatic Headache | 15 | 2023 | 74 | 9.520 |
Why?
|
| Tension-Type Headache | 7 | 2022 | 77 | 3.920 |
Why?
|
| Migraine Disorders | 20 | 2023 | 1620 | 3.790 |
Why?
|
| Calcitonin Gene-Related Peptide | 10 | 2022 | 306 | 3.680 |
Why?
|
| Brain Concussion | 8 | 2023 | 1320 | 2.890 |
Why?
|
| Headache | 13 | 2023 | 1226 | 1.540 |
Why?
|
| Cluster Headache | 3 | 2022 | 54 | 1.350 |
Why?
|
| Headache Disorders, Secondary | 2 | 2021 | 36 | 0.960 |
Why?
|
| Vascular Headaches | 1 | 2023 | 22 | 0.900 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 2 | 2022 | 102 | 0.790 |
Why?
|
| Analgesics | 3 | 2023 | 1040 | 0.670 |
Why?
|
| Central Nervous System Agents | 1 | 2017 | 72 | 0.580 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 867 | 0.530 |
Why?
|
| Hypersensitivity | 2 | 2020 | 1102 | 0.500 |
Why?
|
| Maternal Behavior | 1 | 2017 | 311 | 0.490 |
Why?
|
| Nerve Fibers | 1 | 2017 | 687 | 0.450 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 850 | 0.430 |
Why?
|
| Retinal Ganglion Cells | 1 | 2017 | 770 | 0.390 |
Why?
|
| Retinal Diseases | 1 | 2017 | 683 | 0.380 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 2408 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 9274 | 0.240 |
Why?
|
| Humans | 40 | 2023 | 744343 | 0.230 |
Why?
|
| Double-Blind Method | 4 | 2020 | 12026 | 0.210 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2022 | 19 | 0.210 |
Why?
|
| Neck Pain | 2 | 2020 | 180 | 0.210 |
Why?
|
| Inflammation | 1 | 2021 | 10638 | 0.190 |
Why?
|
| Whiplash Injuries | 1 | 2020 | 15 | 0.190 |
Why?
|
| Smoking | 1 | 2017 | 8987 | 0.180 |
Why?
|
| Migraine without Aura | 1 | 2020 | 83 | 0.180 |
Why?
|
| Neck Muscles | 1 | 2020 | 104 | 0.180 |
Why?
|
| Denmark | 2 | 2021 | 738 | 0.170 |
Why?
|
| Headache Disorders | 1 | 2021 | 130 | 0.170 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 666 | 0.160 |
Why?
|
| Pain Threshold | 1 | 2022 | 584 | 0.160 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 134 | 0.160 |
Why?
|
| Vertigo | 1 | 2020 | 202 | 0.160 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 2029 | 0.160 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2017 | 52 | 0.150 |
Why?
|
| Cyclic GMP | 1 | 2019 | 409 | 0.150 |
Why?
|
| Calcitonin | 1 | 2019 | 336 | 0.150 |
Why?
|
| Dizziness | 1 | 2020 | 251 | 0.150 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2020 | 213 | 0.140 |
Why?
|
| Adult | 10 | 2023 | 214055 | 0.140 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 2274 | 0.140 |
Why?
|
| Prevalence | 5 | 2023 | 15226 | 0.130 |
Why?
|
| Cyclic AMP | 1 | 2019 | 1472 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2022 | 53288 | 0.120 |
Why?
|
| Pain | 3 | 2022 | 4986 | 0.110 |
Why?
|
| Optic Disk | 1 | 2017 | 400 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 9959 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2020 | 4266 | 0.110 |
Why?
|
| Consensus | 1 | 2021 | 2959 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 2647 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1580 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.090 |
Why?
|
| Male | 9 | 2022 | 350118 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2021 | 3743 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2025 | 0.080 |
Why?
|
| Female | 9 | 2022 | 380194 | 0.080 |
Why?
|
| Birth Weight | 1 | 2017 | 2069 | 0.080 |
Why?
|
| Visual Acuity | 1 | 2017 | 2530 | 0.080 |
Why?
|
| Middle Aged | 6 | 2020 | 213383 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 2657 | 0.060 |
Why?
|
| Disease Progression | 1 | 2021 | 13284 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 35421 | 0.060 |
Why?
|
| Animals | 4 | 2021 | 168757 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
| Cognition | 1 | 2021 | 6770 | 0.060 |
Why?
|
| Phenotype | 1 | 2020 | 16365 | 0.050 |
Why?
|
| Trigeminal Ganglion | 1 | 2022 | 186 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39050 | 0.040 |
Why?
|
| Video Recording | 1 | 2022 | 949 | 0.040 |
Why?
|
| Risk Factors | 3 | 2020 | 72290 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2020 | 63114 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 1792 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 85781 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 29144 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 77449 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2021 | 2634 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2022 | 1099 | 0.030 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 163280 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2282 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2021 | 4558 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19905 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3674 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 12804 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 26385 | 0.010 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_